U.S. Capital Wealth Advisors LLC decreased its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 60.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,263 shares of the company's stock after selling 62,896 shares during the quarter. U.S. Capital Wealth Advisors LLC's holdings in Haleon were worth $428,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of HLN. Bartlett & CO. Wealth Management LLC grew its holdings in shares of Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after acquiring an additional 1,491 shares during the last quarter. Banque Transatlantique SA acquired a new stake in shares of Haleon during the 1st quarter valued at $27,000. Opal Wealth Advisors LLC purchased a new position in shares of Haleon during the 1st quarter valued at $29,000. Ransom Advisory Ltd acquired a new position in shares of Haleon in the first quarter worth $31,000. Finally, Deutsche Bank AG increased its stake in shares of Haleon by 267.8% in the first quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock worth $32,000 after acquiring an additional 2,276 shares during the last quarter. Institutional investors own 6.67% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on HLN shares. Barclays lowered Haleon from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, September 16th. The Goldman Sachs Group raised Haleon from a "neutral" rating to a "buy" rating in a research report on Wednesday, September 10th. Finally, Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $12.33.
Read Our Latest Stock Analysis on Haleon
Haleon Price Performance
Shares of NYSE:HLN opened at $8.74 on Friday. The business has a 50 day moving average price of $9.59 and a 200 day moving average price of $10.13. Haleon PLC Sponsored ADR has a twelve month low of $8.71 and a twelve month high of $11.42. The company has a market cap of $39.12 billion, a price-to-earnings ratio of 22.42, a PEG ratio of 2.62 and a beta of 0.24. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48.
Haleon Increases Dividend
The business also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Stockholders of record on Friday, August 15th were issued a $0.0555 dividend. This represents a dividend yield of 190.0%. The ex-dividend date of this dividend was Friday, August 15th. This is a boost from Haleon's previous semi-annual dividend of $0.05. Haleon's payout ratio is currently 28.21%.
Haleon Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Read More
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
